DK27287A - Fremgangsmaade til fremstilling af pertussisantigener - Google Patents

Fremgangsmaade til fremstilling af pertussisantigener

Info

Publication number
DK27287A
DK27287A DK027287A DK27287A DK27287A DK 27287 A DK27287 A DK 27287A DK 027287 A DK027287 A DK 027287A DK 27287 A DK27287 A DK 27287A DK 27287 A DK27287 A DK 27287A
Authority
DK
Denmark
Prior art keywords
lpf
produced
fha
procedure
preparation
Prior art date
Application number
DK027287A
Other languages
English (en)
Other versions
DK27287D0 (da
DK172936B1 (da
Inventor
Andrew Robinson
Lawrence Ian Irons
Original Assignee
Health Lab Service Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Lab Service Board filed Critical Health Lab Service Board
Publication of DK27287D0 publication Critical patent/DK27287D0/da
Publication of DK27287A publication Critical patent/DK27287A/da
Application granted granted Critical
Publication of DK172936B1 publication Critical patent/DK172936B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK198700272A 1986-01-20 1987-01-19 Fremgangsmåde til samtidig fremstilling af lymphocytosefremkaldende faktor (LPF), filamentøst hæmagglutinin (FHA) og mindst DK172936B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8601279 1986-01-20
GB868601279A GB8601279D0 (en) 1986-01-20 1986-01-20 Purification of pertussis antigens

Publications (3)

Publication Number Publication Date
DK27287D0 DK27287D0 (da) 1987-01-19
DK27287A true DK27287A (da) 1987-07-21
DK172936B1 DK172936B1 (da) 1999-10-11

Family

ID=10591636

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198700272A DK172936B1 (da) 1986-01-20 1987-01-19 Fremgangsmåde til samtidig fremstilling af lymphocytosefremkaldende faktor (LPF), filamentøst hæmagglutinin (FHA) og mindst

Country Status (11)

Country Link
US (1) US4784589A (da)
EP (1) EP0231083B1 (da)
JP (1) JP2538224B2 (da)
KR (1) KR950010323B1 (da)
CN (1) CN1028206C (da)
AT (1) ATE92335T1 (da)
AU (1) AU592727B2 (da)
CA (1) CA1280693C (da)
DE (1) DE3786806T2 (da)
DK (1) DK172936B1 (da)
GB (1) GB8601279D0 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337859C (en) * 1987-04-24 1996-01-02 Masashi Chazono Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine
GB8807860D0 (en) * 1988-04-05 1988-05-05 Connaught Lab Pertussis vaccine
CA1341123C (en) * 1988-10-27 2000-10-17 David A. Relman Filamentous hemagglutinin of b. pertussis
JP2706792B2 (ja) * 1988-11-29 1998-01-28 財団法人化学及血清療法研究所 百日咳毒素のトキソイド化法
GB8910570D0 (en) * 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US5391715A (en) * 1989-11-06 1995-02-21 Smithkline Beecham Biologicals Method for isolating and purifying bordetella pertussis antigenic factors
DE69025375T2 (de) 1989-11-06 1996-08-01 Smithkline Beecham Biolog Verfahren
JP3035712B2 (ja) * 1990-02-12 2000-04-24 スミスクライン ビーチャム バイオロジカルズ（エス ア） 新規なワクチンおよびそのための方法
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
US5445817A (en) * 1992-08-21 1995-08-29 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
WO1995029934A1 (en) * 1994-04-28 1995-11-09 Takeda Chemical Industries, Ltd. Method of separating protective components of bordetella pertussis
EP1234579A1 (en) * 1995-05-04 2002-08-28 Aventis Pasteur Limited Acellular Pertussis Vaccines and Methods of Preparation Thereof
US7091311B2 (en) * 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
MXPA05003057A (es) 2002-09-18 2006-04-18 Johnson & Johnson Metodos para aumentar la produccion de celulas madre hematopoyeticas y plaquetas.
MY172181A (en) 2013-03-08 2019-11-15 Janssen Vaccines & Prevention Bv Acellular pertussis vaccine
CN110358802B (zh) * 2019-08-16 2021-06-18 长春百克生物科技股份公司 一种去除百日咳组分菌毛蛋白2/3内毒素的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247452A (en) * 1978-03-01 1981-01-27 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Purification of pertussis haemagglutinins
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
US4474758A (en) * 1981-11-19 1984-10-02 American Cyanamid Company Haemophilus influenzae type b and pertussis outer membrane component combined vaccine
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
CA1213234A (en) * 1983-03-30 1986-10-28 Akihiro Ginnaga Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
US4551429A (en) * 1983-09-15 1985-11-05 American Home Products Corporation Stimulation of antigen production by Bordetella pertussis
JPS6098988A (ja) * 1983-11-01 1985-06-01 Chemo Sero Therapeut Res Inst Ｌｐｆ−ｈａの精製法
AU571078B2 (en) * 1984-04-14 1988-03-31 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Purification of filamentous hemagglutinin

Also Published As

Publication number Publication date
DK27287D0 (da) 1987-01-19
ATE92335T1 (de) 1993-08-15
US4784589A (en) 1988-11-15
DK172936B1 (da) 1999-10-11
EP0231083A3 (en) 1988-06-08
EP0231083A2 (en) 1987-08-05
JPS62234031A (ja) 1987-10-14
CN1028206C (zh) 1995-04-19
DE3786806D1 (de) 1993-09-09
AU6766487A (en) 1987-07-23
CA1280693C (en) 1991-02-26
GB8601279D0 (en) 1986-02-26
DE3786806T2 (de) 1993-12-09
AU592727B2 (en) 1990-01-18
CN87100399A (zh) 1987-09-09
KR870006902A (ko) 1987-08-13
JP2538224B2 (ja) 1996-09-25
EP0231083B1 (en) 1993-08-04
KR950010323B1 (ko) 1995-09-14

Similar Documents

Publication Publication Date Title
DK27287D0 (da) Fremgangsmaade til fremstilling af pertussisantigener
DK496485D0 (da) Transformation af gaer-stammer af slaegten pichia
MX9708481A (es) Vacunas acelulares de pertussis y metodos de preparacion de las mismas.
ATE107535T1 (de) Gaschromatographische methode zur trennung von wasserstoffisotopen.
NO975434L (no) Fremgangsmåte for fremstilling av influensa hemagglutinin multivalente vaksiner
DK0891420T4 (da) Fremgangsmåde til replikation af influenzavirus i cellekultur samt de ved fremgangsmåden opnåelige influenzavirus
DK0522291T3 (da) Fremgangsmåde til rensning af hepatitis A-virus (HAV), således renset virus og vaccinepræparater indeholdende dette
DK0550509T3 (da) Fremgangsmåde til fremstilling af rensede glycolipider ved membranseparationsmetoden
ATE97448T1 (de) Verfahren zur isolierung von ca 125-antigen.
ATE74007T1 (de) Immunoverstaerker und verfahren zu ihrer herstellung.
DK326289A (da) Fremgangsmaade til fremstilling af et protein ud fra gaersvampe under anvendelse af et inducerbart system, samt vektorer og transformerede stammer til brug ved fremgangsmaaden
ZA908801B (en) Process for purifying antigenic factors from b.pertussis
DK0506714T3 (da) Matrix med adhærent bundne celler og fremgangsmåde til frembringelse af virus/virusantigener
DE3686961D1 (de) Polydisperse native pseudomonas-flagella(h)-antigene (fag) und verfahren zu ihrer gewinnung.
JPS5464683A (en) Preparation of unicellular protein
DK67886A (da) Fremgangsmaade til fremstilling af 4-(2-methoxyethyl)-phenylglycidylether og/eller metoprolol
DK0485504T3 (da) Fremgangsmåde til fremstilling af aktiveret protein C ved celledyrkning
JPS6456620A (en) Production of hemorrhagic fever with renal syndrome virus antigen and vaccine and diagnostic agent using said antigen
JPS5675095A (en) Preparation of heat-resistant acetic acid kinase
DK222887A (da) Fremgangsmaade til fremstilling af l-aminosyrer ved fermentering af alfa-ketocarboxylsyrer
DK0408742T3 (da) Fremgangsmåde til fremstilling og rensning af hepatitis B vaccine
ATE109353T1 (de) Verfahren zur herstellung eines impfstoffs gegen hepatitis b.
JPS5459391A (en) Culturing of edible basidiomycetes
FI98466B (fi) FSME-viruksen läntisen alatyypin eristettyjä DNA- ja RNA-molekyylejä, näitä sisältäviä vektoreita ja soluviljelmiä sekä menetelmä näiden koodittamien peptidien valmistamiseksi
JPS5539730A (en) Preparation of ubiquinone q10

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired